S-Ethylisothiourea Hydrobromide CAS 1071-37-0 Purity >98.0% Ensitrelvir (S-217622) Intermediate COVID-19
Commercial Supply Ensitrelvir (S-217622) Intermediates:
S-Ethylisothiourea Hydrobromide CAS 1071-37-0
2,4,5-Trifluorobenzyl Bromide CAS 157911-56-3
Trimethyloxonium Tetrafluoroborate CAS 420-37-1
6-Chloro-2-methyl-2H-indazol-5-amine CAS 1893125-36-4
3-(Chloromethyl)-1-methyl-1H-1,2,4-triazole hydrochloride CAS 135206-76-7
1,3,5-Triazine-2,4(1H,3H)-dione, 3-(1,1-dimethylethyl)-6-(ethylthio)- CAS 1360105-53-8
Chemical Name | S-Ethylisothiourea Hydrobromide |
CAS Number | 1071-37-0 |
CAT Number | RF-PI1502 |
Stock Status | In Stock, Production Scale Up to Tons |
Molecular Formula | C3H8N2S·HBr |
Molecular Weight | 185.08 |
Melting Point | 79.0~81.0℃ |
Brand | Ruifu Chemical |
Item | Specifications |
Appearance | White to Almost White Powder to Crystal |
Purity | >98.0% |
Loss on Drying | <0.50% |
Single Impurity | <0.50% |
Total Impurities | <2.00% |
Heavy Metals (as Pb) | <20ppm |
Test Standard | Enterprise Standard |
Usage | Pharmaceutical Intermediates; Intermediate of Ensitrelvir (S-217622) |
Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement.
Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture.
S-Ethylisothiourea Hydrobromide (CAS: 1071-37-0) can be used as organic synthesis intermediate and pharmaceutical intermediate. S-Ethylisothiourea Hydrobromide can be used in the synthesis of Ensitrelvir (S-217622). Ensitrelvir (S-217622) is the first orally active non-covalent, non-peptidic, SARS-CoV-2 3CL protease inhibitor (IC50=13 nM).